Posted on

Gilead Sciences’ antiviral drug remdesivir called new standard of care for Covid-19 patients

c1 3618156

the staff of the Ridgewood blog

Ridgewood NJ, A promising drug called remdesivir may shorten hospital stays for patients with COVID-19 and perhaps speed their recoveries while diminishing the odds of death, according to Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who on Wednesday described federal next steps based on the new, positive study.

Continue reading Gilead Sciences’ antiviral drug remdesivir called new standard of care for Covid-19 patients